A Plus Biotechnology Co

A Plus Biotechnology Co PEG

The PEG Ratio (Price/Earnings-to-Growth) of A Plus Biotechnology Co (6918.TWO) as of Oct 18, 2026 is 0.29. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 1.40 — a change of -79.37% (lower).

PEG

0.29

YoY

-79.37%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of A Plus Biotechnology Co is 2024 0.29 . PEG Ratio (Price/Earnings-to-Growth) of A Plus Biotechnology Co was 2023 1.40 . It decreases by -79.37% lower compared to the previous year.

The A Plus Biotechnology Co PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2019
1.40 TWD
Jan 1, 2020
1.21 TWD
Jan 1, 2021
1.32 TWD
Jan 1, 2022
0.95 TWD
Jan 1, 2023
1.40 TWD
Jan 1, 2024
0.29 TWD
The A Plus Biotechnology Co PEG history
YEARPEGYoY
0.29-79.37%
1.40+46.68%
0.95-27.93%
1.32+9.48%
1.21-13.55%
1.40—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

A Plus Biotechnology Co Stock analysis

What does A Plus Biotechnology Co do? A Plus Biotechnology Co Ltd, listed on the Taiwan Stock Exchange with ticker 6918.TWO, operates in the Health Care sector. The company is based in Taipei, Taiwan, and focuses on research, development, and manufacturing of orthopedic medical equipment. Its product portfolio includes trauma products for fracture fixation, orthopedic correction systems, artificial bone replacements, and spinal fixation devices. The company went public on January 6, 2023. Products are sold domestically and exported to mainland China, Asia, the United States, and Africa. A Plus Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about A Plus Biotechnology Co stock

PEG Ratio (Price/Earnings-to-Growth) of A Plus Biotechnology Co is 0.29 in 2024.

PEG Ratio (Price/Earnings-to-Growth) of A Plus Biotechnology Co changed from 1.40 to 0.29, representing a -79.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) A Plus Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s A Plus Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — A Plus Biotechnology Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — A Plus Biotechnology Co